Ebola vaccine, Ervebo, receives final approval in Europe
by Press Release from Outbreak News Today on (#4V0JP)
The European Medicines Agency has recommended granting a conditional marketing authorisation in the European Union for Ervebo (rVSVI"G-ZEBOV-GP), the first vaccine for active immunisation of individuals aged 18 years and older at risk of infection with the Ebola virus. "This is an important step towards relieving the burden of this deadly disease," said Guido Rasi, EMA's Executive Director. The CHMP's ["]
The post Ebola vaccine, Ervebo, receives final approval in Europe appeared first on Outbreak News Today.